LAWRENCE, Mass., Nov. 22 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. , announced plans to release its financial results for the third quarter ended September 30, 2005 on Thursday, December 1, 2005 before the open of the U.S. financial markets.
NxStage will also host a conference call at 9:00 a.m. EST on December 1, 2005 to discuss the third quarter 2005 results. To listen to the conference call, please dial (866) 713-8565 for domestic callers and (617) 597-5324 for international callers. The passcode is 30801770. A replay of the conference call will be available through December 8, 2005 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 80425788. An online archive of the conference call will also be available by accessing the Investor Relations portion of the Company’s website at http://www.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “plan,” and similar expressions are generally intended to identify forward-looking statements. The forward-looking statements in this release include NxStage’s plan to release its financial results on December 1, 2005. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, unexpected difficulty in closing the company’s financial books for the quarter and other factors that are discussed in NxStage’s Registration Statement on Form S-1 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
NxStage Medical, Inc.
CONTACT: David N. Gill, Senior Vice President & Chief Financial Officer ofNxStage Medical, Inc., +1-978-687-4700
Web site: http://www.nxstage.com//
